These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. PPARgamma ligands as modulators of inflammatory and catabolic responses in arthritis. An overview. Fahmi H; Pelletier JP; Martel-Pelletier J J Rheumatol; 2002 Jan; 29(1):3-14. PubMed ID: 11824967 [No Abstract] [Full Text] [Related]
25. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors. Kusunoki N; Yamazaki R; Kawai S Arthritis Rheum; 2002 Dec; 46(12):3159-67. PubMed ID: 12483719 [TBL] [Abstract][Full Text] [Related]
26. Effects of actarit on synovial cell functions in patients with rheumatoid arthritis. Takeba Y; Suzuki N; Wakisaka S; Nagafuchi H; Mihara S; Kaneko A; Asai T; Sakane T J Rheumatol; 1999 Jan; 26(1):25-33. PubMed ID: 9918236 [TBL] [Abstract][Full Text] [Related]
27. Prostaglandins and their precursors in rheumatoid arthritis: progress and problems. Kirkpatrick CJ; Mohr W; Haferkamp O Z Rheumatol; 1982; 41(3):89-99. PubMed ID: 6810578 [TBL] [Abstract][Full Text] [Related]
30. Induction of cyclooxygenase-1 in cultured synovial cells isolated from rheumatoid arthritis patients. Onodera M; Horiuchi Y; Nakahama K; Muneta T; Mano Y; Morita I Inflamm Res; 2004 Jun; 53(6):217-22. PubMed ID: 15167967 [TBL] [Abstract][Full Text] [Related]
31. Prostaglandin D2 and prostaglandin E2 accelerate the recovery of cutaneous barrier disruption induced by mechanical scratching in mice. Honma Y; Arai I; Hashimoto Y; Futaki N; Sugimoto M; Tanaka M; Nakaike S Eur J Pharmacol; 2005 Jul; 518(1):56-62. PubMed ID: 16000196 [TBL] [Abstract][Full Text] [Related]
32. Hydrolytic activity is essential for aceclofenac to inhibit cyclooxygenase in rheumatoid synovial cells. Yamazaki R; Kawai S; Matsumoto T; Matsuzaki T; Hashimoto S; Yokokura T; Okamoto R; Koshino T; Mizushima Y J Pharmacol Exp Ther; 1999 May; 289(2):676-81. PubMed ID: 10215639 [TBL] [Abstract][Full Text] [Related]
33. [The role of lipid mediators in allergic diseases]. Nagai H Arerugi; 2007 Jun; 56(6):570-6. PubMed ID: 17615500 [No Abstract] [Full Text] [Related]
34. The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis. Tak PP; Bresnihan B Arthritis Rheum; 2000 Dec; 43(12):2619-33. PubMed ID: 11145019 [No Abstract] [Full Text] [Related]
35. Induction of COX-2 expression by nitric oxide in rheumatoid synovial cells. Honda S; Migita K; Hirai Y; Ueki Y; Yamasaki S; Urayama S; Kawabe Y; Fukuda T; Kawakami A; Kamachi M; Kita M; Ida H; Aoyagi T; Eguchi K Biochem Biophys Res Commun; 2000 Feb; 268(3):928-31. PubMed ID: 10679307 [TBL] [Abstract][Full Text] [Related]
36. Upregulation of synoviocyte COX-2 through interactions with T lymphocytes: role of interleukin 17 and tumor necrosis factor-alpha. Stamp LK; Cleland LG; James MJ J Rheumatol; 2004 Jul; 31(7):1246-54. PubMed ID: 15229940 [TBL] [Abstract][Full Text] [Related]
37. Fish oil supplementation increases the cyclooxygenase inhibitory activity of paracetamol in rheumatoid arthritis patients. Caughey GE; James MJ; Proudman SM; Cleland LG Complement Ther Med; 2010; 18(3-4):171-4. PubMed ID: 20688263 [TBL] [Abstract][Full Text] [Related]